Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSCARNET vs FREMANEZUMAB-VFRM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSCARNET vs FREMANEZUMAB-VFRM: Safety Overview

Metric FOSCARNET FREMANEZUMAB-VFRM
Total FAERS Reports 2,057 9,103
Deaths Reported 605 74
Death Rate 29.4% 0.8%
Hospitalizations 608 558
Average Patient Age 41.8 yrs 49.5 yrs
% Female Patients 40.6% 89.2%
FDA Approval Date Apr 21, 2021 N/A
Manufacturer Hikma Pharmaceuticals USA Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Prescription Prescription